Copyright
©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Dec 28, 2013; 19(48): 9351-9358
Published online Dec 28, 2013. doi: 10.3748/wjg.v19.i48.9351
Published online Dec 28, 2013. doi: 10.3748/wjg.v19.i48.9351
Epidemiology and clinical features of cystic hydatidosis in Western Sicily: A ten-year review
Elisa Cappello, Bruno Cacopardo, Eleonora Caltabiano, Luciano Nigro, Department of Clinical and Molecular Biomedicine, Chair of Infectious Diseases, University of Catania, 95124 Catania, Italy
Sigismindo Li Volsi, Rosa Chiara, Mauro Sapienza, Unit of Infectious Diseases, “Basilotta” Hospital, 95014 Nicosia, Italy
Author contributions: Cappello E contributed to the research project design, data analysis and main authorship; Cacopardo B contributed to the research project design support, provision of analytical instruments, and secondary authorship; Caltabiano E and Li Volsi S contributed to the patient enrolment; Chiara R contributed to the ultrasound examinations; Sapienza M supported the data analysis; Nigro L contributed project leadership and supervision.
Correspondence to: Luciano Nigro, MD, Professor, Department of Molecular and Clinical Biomedicine, Chair of Infectious Diseases, University of Catania, c/o Ferrarotto Hospital, via Citelli n.8, 95124 Catania, Italy. nigrolu@unict.it
Telephone: +39-95-7436253 Fax: +39-95-7435957
Received: June 13, 2013
Revised: September 27, 2013
Accepted: October 17, 2013
Published online: December 28, 2013
Revised: September 27, 2013
Accepted: October 17, 2013
Published online: December 28, 2013
Core Tip
Core tip: On the basis of the data presented, we suggest the use of specific immunoglobulin E detection and eosinophil percentage counts as therapeutic response markers, particularly in settings with limited resources. We also recommend: (1) routine screening for cystic echinococcosis in relatives (and/or close associates) of patients to facilitate the diagnosis of asymptomatic infection; (2) extension of the follow-up period after surgical and/or medical treatment for the early diagnosis of relapses; and (3) appropriate pre- and post-surgery therapy.